Kyung-Min Yang Selected Research

Drug Therapy (Chemotherapy)

1/2022	Degradation of DRAK1 by CUL3/SPOP E3 Ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells.
11/2020	ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung-Min Yang Research Topics

Disease

15	Neoplasms (Cancer) 12/2022 - 01/2015
8	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2015
6	Breast Neoplasms (Breast Cancer) 03/2018 - 11/2013
4	Triple Negative Breast Neoplasms 01/2021 - 12/2017
3	Inflammation (Inflammations) 01/2020 - 10/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2020
2	Carcinogenesis 01/2018 - 12/2017
1	Osteoporosis 11/2023
1	Colitis 07/2023
1	Aggressive Fibromatosis (Desmoid) 12/2022
1	Stomach Neoplasms (Stomach Cancer) 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Oncogene Addiction 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 03/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Ureteral Obstruction 11/2013
1	Fibrosis (Cirrhosis) 11/2013

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2019
6	Phosphotransferases (Kinase)IBA 01/2022 - 11/2013
3	Death-Associated Protein KinasesIBA 01/2022 - 01/2016
3	UbiquitinIBA 01/2019 - 12/2015
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2020
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 12/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 01/2016
2	RNA (Ribonucleic Acid)IBA 03/2018 - 01/2018
2	Phenobarbital (Luminal)FDA Link 12/2015 - 01/2015
1	Dextran SulfateIBA 07/2023
1	beta CateninIBA 12/2022
1	Protein Isoforms (Isoforms)IBA 10/2022
1	Leucine (L-Leucine)FDA Link 10/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2021
1	PhytochemicalsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	PlatinumIBA 11/2020
1	Sirtuin 2IBA 11/2020
1	CytokinesIBA 01/2020
1	LysophospholipidsIBA 01/2020
1	LipidsIBA 01/2020
1	Estrogens (Estrogen)FDA Link 12/2019
1	PolyubiquitinIBA 12/2019
1	VimentinIBA 12/2019
1	human ERBB2 proteinIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	FlavonoidsIBA 12/2017
1	galanginIBA 12/2017
1	Annexin A2 (Annexin II)IBA 12/2017
1	Cathepsin BIBA 12/2017
1	Lysine (L-Lysine)FDA Link 10/2017
1	EnzymesIBA 10/2017
1	Arginine (L-Arginine)FDA Link 10/2017
1	Peptide Elongation Factors (Elongation Factor)IBA 12/2015
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2015
1	Metalloproteases (Metalloproteinases)IBA 01/2015
1	Estrogen ReceptorsIBA 11/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2013
1	Glucosamine (Dona)IBA 11/2013

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 11/2020
2	Therapeutics 01/2021 - 12/2015
1	Radiotherapy 12/2022